|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tscan Therapeutics, Inc. (TCRX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
43,550,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TScan Therapeutics is a clinical-stage biopharmaceutical company focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s proprietary platform is designed to: discover anti-cancer TCRs from patients with exceptional responses to immunotherapy; discover TCRs that recognize clinically validated targets; identify off-targets of TCRs to eliminate candidates; and manufacture TCR-T therapies using Co.'s T-Integrate technology. The central elements of Co.'s platform that differentiate it from other cell therapy companies are TargetScan, ReceptorScan, SafetyScan, ImmunoBank and T-Integrate.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
34,147 |
72,027 |
103,027 |
| Total Buy Value |
$0 |
$167,856 |
$267,420 |
$366,458 |
| Total People Bought |
0 |
2 |
2 |
4 |
| Total Buy Transactions |
0 |
3 |
4 |
7 |
| Total Shares Sold |
0 |
0 |
25,400 |
25,400 |
| Total Sell Value |
$0 |
$0 |
$63,953 |
$63,953 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Westphal Christoph H |
10% Owner |
– – • |
2021-07-20 |
4 |
B |
$15.00 |
$1,999,995 |
I/I |
133,333 |
1,278,838 |
1.5 |
- |
|
| Westphal Christoph H |
10% Owner |
– – • |
2021-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,145,505 |
1,145,505 |
|
- |
|
| Silver Brian M. |
Chief Financial Officer |
• – – |
2021-07-20 |
4 |
B |
$15.00 |
$15,000 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Barberich Timothy J |
Director |
– • – |
2021-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
33,259 |
33,259 |
|
- |
|
| Baker Julian |
Director |
– • – |
2021-07-20 |
4 |
B |
$15.00 |
$21,375,000 |
I/I |
1,425,000 |
1,320,302 |
2.1 |
- |
|
30 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
